Study to Evaluate the Safety and Efficacy of Vesatolimod in Antiretroviral Treated Human Immunodeficiency Virus (HIV-1) Infected Controllers
Clinical trial NCT03060447 · COMPLETED
Trial details
- NCT number
- NCT03060447
- Sponsor
- Gilead Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-09
- Primary completion
- 2020-02-13
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.